Psychometric Validation of the Camouflaging Autistic Traits Questionnaire

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

622 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-20

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For many affected individuals, despite impairment and distress, autism spectrum disorder (ASD) is recognized and diagnosed late, in school age, adolescence, or even in adulthood, which could be due, among other things, to the use of compensatory strategies such as so-called "camouflaging" by the respective individual. In order to better investigate and quantify these adaptive and compensatory strategies of individuals with autism, the Camouflaging Autistic Traits Questionnaire (CAT-Q) has recently been developed and validated in the English-speaking world. The CAT-Q is designed to assess the extent of camouflaging behavior, in which autistic individuals consciously or unconsciously attempt to conceal or attenuate their autistic traits in order to better adapt to social situations. So far, however, there is no German-language questionnaire that can be used to validly assess camouflaging. The aim of the planned research project is to psychometrically validate the CAT-Q in German-speaking adolescents aged 13-21 years. The validation of the CAT-Q represents an important basis for further research on the construct camouflaging and can subsequently contribute to an improvement of diagnostics as well as support the development of individual treatment approaches.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design

NCT05200351

Emotion Regulation Autism Spectrum Disorder Adolescent - Emotional Problem

RECRUITING NA

Parenting with an Autism Spectrum Disorder

NCT06502054

Autism Spectrum Disorder

RECRUITING

Aut-CARE Intervention to Improve Cognitive and Emotional Functioning in Young Adults on the Autism Spectrum

NCT07041502

Autism Spectrum Disorder Autism Spectrum Disorder With Absence of Functional Language

RECRUITING

Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency

NCT02747056

Autism Spectrum Disorders

COMPLETED NA

Multicenter Validation Study on Autism Screening Using a Machine-assisted System

NCT07006948

Autism Spectrum Disorder Early Developmental Impairment Language Development Disorders

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Adolescents between the ages of 13-21 who meet diagnostic criteria for an autism spectrum disorder.

No interventions assigned to this group

Control group

Adolescents aged 13-21 years without a lifetime psychiatric diagnosis.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- patients who meet the principal diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), and are between the ages of 13 and 21 years old.

\- Adolescents who do not have a lifetime principal diagnosis of a psychiatric disorder (ICD-10-GM-2016: F10 - F69) and are between 13 and 21 years old.

Exclusion Criteria

* Dementia / below average cognitive abilities (IQ \< 85)
* lack of German language skills
* severe visual or hearing impairment (uncorrected)

* dementia / below average general cognitive ability (IQ \< 85)
* lack of German language skills
* severe impairment of vision or hearing (not corrected).

Minimum Eligible Age

13 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No